US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist

9.460
-0.890-8.60%

Close Mar 10 16:00 ET

9.680
+0.220+2.33%

Pre 08:32 ET

979.28MMarket Cap-1.80P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intellia Therapeutics Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	8.10M	12.87M	+4.77M
Beat Est.	+522.52%	+771.57%	+58.94%
EPS	-1.33	-1.27	+0.06
Beat Est.	+8.64%	+13.01%	+4.78%

Analyst Rating

Buy

Mar 5, 2025

Intellia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 19 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 11.230M	--
--	2025/Q1	-- / 11.334M	--
Feb 27, 2025	2024/Q4	12.874M / 8.100M	--
Nov 7, 2024	2024/Q3	9.111M / 7.170M	--
Aug 8, 2024	2024/Q2	6.957M / 18.277M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 11.230M--

--2025/Q1-- / 11.334M--

Feb 27, 20252024/Q412.874M / 8.100M--

Nov 7, 20242024/Q39.111M / 7.170M--

Aug 8, 20242024/Q26.957M / 18.277M--

Unlock Free Earnings Estimates

Open Account

Intellia Therapeutics Earnings Reports

Intellia Therapeutics | 10-K: FY2024 Annual Report

Feb 27 16:04 ET

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress

Feb 27 07:45 ET

Intellia Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:08 ET

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

Nov 7, 2024 07:48 ET

Trending Stocks

Symbol Mini Chart % Chg

Lantheus

LNTH

+3.45%

Collegium Pharmaceutical

COLL